CAMBRIDGE, Mass. and SUZHOU, China, Dec. 16, 2020 /PRNewswire/ -- HBM Holdings Limited ("Harbour BioMed", "HBM" or the "Company"; Stock Code: 02142.HK), a global clinical-stage biopharmaceutical company, completed its global offering (the "Global Offering") and its listing on the Main...
from PR Newswire: https://ift.tt/2Kv4yiP
No comments:
Post a Comment